Dear all,
Welcome to week two of our discussion on Open Access, and in particular to those who have joined us over the past seven days! We look forward to learning from your experience and expertise. To contribute, please send an email to: hifa@hifaforums.org You can review past messages on our RSS feed here: https://www.hifa.org/rss-feeds/17
Here again is our landing page for further information: https://www.hifa.org/news/hifa-announces-deep-dive-discussion-healthcare...
This week (20-27 October) we are looking at Q2: *What is your experience of OA as a healthcare professional/reader?*
The benefits of open access publishing are well established, as outlined in the UNESCO recommendations on open science (https://www.unesco.org/en/legal-affairs/recommendation-open-science). Despite this, healthcare professionals perceptions and experiences of open access publishing have not been well documented.
To address this knowledge gap, we are keen to explore the following factors:
• How important is open access publishing for healthcare professionals?
• What are the perceived benefits and barriers of open access publishing for healthcare professionals, as readers and users of scientific content?
• What is the impact of *not* publishing open access on healthcare professionals, especially for those who *do not* have access via an institutional subscription?
We are especially interested to hear actual practical examples and observations. For example, can you describe a situation where (lack of) access to the full text of a paper has impacted a healthcare professional's ability to optimally manage a patient?
Please do feel free to comment on any aspect of open access that you feel is relevant to this discussion.
As a reminder, the HIFA Open Access working group proposes the following guiding questions:
1. What is the impact of open access (OA) on health care? (last week)
2. What is your experience of OA as a healthcare professional/reader? (this week)
3. What is your experience of OA as a researcher/author? (next week)
4. How would you design an OA system that retains the benefits but fixes the problems of the current OA system?
5. Open discussion and next steps.
We look forward to your contributions: hifa@hifaforums.org
Many thanks, Joanna
Joanna Donnelly PhD
Communications Consultant
Let us know how we’re doing
Oxford PharmaGenesis Ltd
UK Tel: +44 1865 390144
joanna.donnelly@pharmagenesis.com
www.pharmagenesis.com
Oxford PharmaGenesis Ltd is registered in England and Wales, registration number 03488862. Our registered office is at Tubney Warren Barn, Tubney, Oxford, OX13 5QJ, UK.
HIFA profile: Joanna Donnelly DPhil is a Communications Consultant at Oxford PharmaGenesis and leads the open access working group and AI discussion forum at Open Pharma, a multi-sponsor collaboration facilitated by Oxford PharmaGenesis seeking to drive transparency in the communication of pharma-sponsored research. She is a member of the HIFA Open Access working group. https://www.hifa.org/support/members/joanna